1. A PHASE I TRIAL OF TARGETED IMMUNOTHERAPY WITH DARATUMUMAB FOLLOWING MYELOABLATIVE TOTAL BODY IRRADIATION (TBI)-BASED CONDITIONING AND ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATON IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH HIGH-RISK T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOMA (T- ALL/T-LLy) (ALLO-T-DART) (IND 159396): A PTCTC FACILITATED STUDY. (October 2022) Authors: Quigg, T.; Flower, A.; Teachey, D.; Lim, M.; Chu, Y.; Harrison, L.; Morris, E.; Gardenswartz, A.; Hochberg, J.; Ozkaynak, M.; Rosenblum, J.; Milner, J.; Pehlivan, K.; Levendoglu-Tugal, O.; Fabricatore, S.; Wolownik, K.; Ayello, J.; Rigot, O.; Klejmont, L.; Campbell, M. Journal: Leukemia research Issue: Volume 121(2022)Supplement Page Start: S71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A TARGETED GENE EXPRESSION CLASSIFIER IDENTIFIES PEDIATRIC T-ALL PATIENTS AT HIGH RISK FOR END INDUCTION MINIMAL RESIDUAL DISEASE POSITIVITY. (October 2022) Authors: Meyer, L.; Roy, Ritu P.; Huang, B.; Kimura, S.; Polonen, Petri; Delgado-Martin, C.; Vincent, T.; Ryan, T.; Wood, B.; Liu, Y.; Zhang, J.; Mullighan, C.; Horton, T.; Loh, M.; Devidas, M.; Raetz, E.; Hayashi, R.; Winter, S.; Dunsmore, K.; Hunger, S. Journal: Leukemia research Issue: Volume 121(2022)Supplement Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P360: EFFICACY AND SAFETY OF DARATUMUMAB IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA OR LYMPHOBLASTIC LYMPHOMA: RESULTS FROM PHASE 2 DELPHINUS STUDY. (23rd June 2022) Authors: Vora, A.; Bhatla, T.; Teachey, D.; Bautista, F.; Moppett, J.; Velasco Puyó, P.; Micalizzi, C.; Rossig, C.; Shukla, N.; Gilad, G.; Locatelli, F.; Baruchel, A.; Zwaan, C. M.; Raetz, E. A.; Bandyopadhyay, N.; Lopez Solano, L.; Dennis, R. M.; Carson, R.; Hogan, L. E. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗